122 related articles for article (PubMed ID: 20411477)
21. [Melatonin inhibits the proliferation of pituitary prolactin-secreting tumor by suppressing the enhancer elements mutation of PRL gene in the rat].
Gao L; Yang QH; Xu RK
Sheng Li Xue Bao; 2005 Jun; 57(3):319-27. PubMed ID: 15968426
[TBL] [Abstract][Full Text] [Related]
22. Effects of Vasoactive Intestinal Polypeptide and Forskolin on mRNA Expression of Prolactin and Prolactin Regulatory Element-Binding Protein in the Anterior Pituitary Gland of Chicken Embryo and Laying Hens.
Kansaku N; Tobari Y; Hiyama G; Wakui S; Minoguchi N; Numata M; Kino K; Zadworny D
J Poult Sci; 2016 Oct; 53(4):313-317. PubMed ID: 32908399
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of transcriptional activation of the promoter of the rainbow trout prolactin gene by GHF1/Pit1 and glucocorticoid.
Argenton F; Ramoz N; Charlet N; Bernardini S; Colombo L; Bortolussi M
Biochem Biophys Res Commun; 1996 Jul; 224(1):57-66. PubMed ID: 8694834
[TBL] [Abstract][Full Text] [Related]
24. Prolactin in the brushtail possum (Trichosurus vulpecula): development of homologous radioimmunoassay using recombinant possum prolactin.
Crawford JL; Lun S; Demmer J; Eckery DC
Gen Comp Endocrinol; 2005 Jul; 142(3):297-307. PubMed ID: 15935156
[TBL] [Abstract][Full Text] [Related]
25. Convergent evolution of endometrial prolactin expression in primates, mice, and elephants through the independent recruitment of transposable elements.
Emera D; Casola C; Lynch VJ; Wildman DE; Agnew D; Wagner GP
Mol Biol Evol; 2012 Jan; 29(1):239-47. PubMed ID: 21813467
[TBL] [Abstract][Full Text] [Related]
26. PREB regulates transcription of pancreatic glucokinase in response to glucose and cAMP.
Muraoka T; Murao K; Imachi H; Yu X; Li J; Wong NC; Ishida T
J Cell Mol Med; 2009 Aug; 13(8B):2386-2395. PubMed ID: 19267880
[TBL] [Abstract][Full Text] [Related]
27. Effects of calcium and calcium ionophores on prolactin gene expression in GH3 and 235-1 rat pituitary tumor cells.
Delidow BC; Lail-Trecker M; White BA
Mol Endocrinol; 1992 Aug; 6(8):1268-76. PubMed ID: 1406704
[TBL] [Abstract][Full Text] [Related]
28. Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.
Gao H; Wang F; Lan X; Li C; Feng J; Bai J; Cao L; Gui S; Hong L; Zhang Y
BMC Cancer; 2015 Apr; 15():272. PubMed ID: 25884948
[TBL] [Abstract][Full Text] [Related]
29. Characterization and Expression of Turkey Prolactin Regulatory Element Binding in the Anterior Pituitary Gland and Pancreas During Embryogenesis.
Hiyama G; Kansaku N; Wakui S; McQuaid R; Zadworny D
J Poult Sci; 2016 Jan; 53(1):67-75. PubMed ID: 32908367
[TBL] [Abstract][Full Text] [Related]
30. CEBPD suppresses prolactin expression and prolactinoma cell proliferation.
Tong Y; Zhou J; Mizutani J; Fukuoka H; Ren SG; Gutierrez-Hartmann A; Koeffler HP; Melmed S
Mol Endocrinol; 2011 Nov; 25(11):1880-91. PubMed ID: 21980073
[TBL] [Abstract][Full Text] [Related]
31. Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas.
Zhang D; Way JS; Zhang X; Sergey M; Bergsneider M; Wang MB; Yong WH; Heaney AP
J Clin Endocrinol Metab; 2019 Jun; 104(6):1929-1936. PubMed ID: 30624667
[TBL] [Abstract][Full Text] [Related]
32. Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: in vitro culture studies.
Eguchi K; Kawamoto K; Uozumi T; Ito A; Arita K; Kurisu K
Endocr J; 1995 Jun; 42(3):413-20. PubMed ID: 7670571
[TBL] [Abstract][Full Text] [Related]
33. Effect of an injectable cabergoline formulation on serum prolactin (PRL) and milk secretion in early postpartum Beagle bitches.
Romagnoli S; Milani C; Perin S; Ballabio R; Stelletta C; Mollo A; Gelli D
Reprod Domest Anim; 2009 Jul; 44 Suppl 2():148-51. PubMed ID: 19754555
[TBL] [Abstract][Full Text] [Related]
34. Prolactin-deficient GH3B3 cells are defective in the utilization of the endogenous prolactin promoter yet are fully competent to initiate transcription from a transfected prolactin promoter.
Arnold TE; Farrance IK; Morris J; Ivarie R
DNA Cell Biol; 1991 Mar; 10(2):105-12. PubMed ID: 1706185
[TBL] [Abstract][Full Text] [Related]
35. Up- and Down-regulated Leukemia-related Protein 16 Affects ERα Expression and Prolactin Secretion by GH3 Cells.
Su X; Wu ZQ; Yang XJ; Wang AP; Zhao K; Wu TG; Sun Y; Sun J; Chang ZY; Guo XY; Guo QH; Mu YM
Biomed Environ Sci; 2017 Dec; 30(12):938-942. PubMed ID: 29335066
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary.
Dall'Ara A; Lima L; Cocchi D; Di Salle E; Cancio E; Devesa J; Müller EE
Eur J Pharmacol; 1988 Jun; 151(1):97-102. PubMed ID: 3416930
[TBL] [Abstract][Full Text] [Related]
37. HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy.
Fukuoka H; Cooper O; Mizutani J; Tong Y; Ren SG; Bannykh S; Melmed S
Mol Endocrinol; 2011 Jan; 25(1):92-103. PubMed ID: 21106881
[TBL] [Abstract][Full Text] [Related]
38. The multiple endocrine neoplasia type 1 gene product, menin, inhibits the human prolactin promoter activity.
Namihira H; Sato M; Murao K; Cao WM; Matsubara S; Imachi H; Niimi M; Dobashi H; Wong NC; Ishida T
J Mol Endocrinol; 2002 Dec; 29(3):297-304. PubMed ID: 12459032
[TBL] [Abstract][Full Text] [Related]
39. Inhibiting MAPK14 showed anti-prolactinoma effect.
Ding QY; Zhang Y; Ma L; Chen YG; Wu JH; Zhang HF; Wang X
BMC Endocr Disord; 2020 Sep; 20(1):138. PubMed ID: 32894113
[TBL] [Abstract][Full Text] [Related]
40. The Balance of PI3K and ERK Signaling Is Dysregulated in Prolactinoma and Modulated by Dopamine.
Roof AK; Jirawatnotai S; Trudeau T; Kuzyk C; Wierman ME; Kiyokawa H; Gutierrez-Hartmann A
Endocrinology; 2018 Jun; 159(6):2421-2434. PubMed ID: 29726995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
